ALITAIR PHARMACEUTICALS, INC.

DEAD

Serial Number

87436315

Owner

Alitair Pharmaceuticals, Inc.

Filing Date

May 4, 2017

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ALITAIR PHARMACEUTICALS, INC. Trademark

Serial Number: 87436315

ALITAIR PHARMACEUTICALS, INC. is a trademark filed by Alitair Pharmaceuticals, Inc. on May 4, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 40 - Treatment & Processing

Treatment of materials

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Alitair Pharmaceuticals, Inc. (6 trademarks)

55 Madison Avenue, Suite 400
Morristown, NJ 07960

Entity Type: 03

Legal Representation

Correspondence Address

Alitair Pharmaceuticals, Inc.

55 Madison Avenue

Suite 400

Morristown

NJ 07960

Trademark Details

Filing Date

May 4, 2017

Registration Date

Not Registered

Published for Opposition

September 5, 2017

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Jun 3, 2019 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Jun 3, 2019 ABN6

WITHDRAWAL OF ATTORNEY GRANTED

Feb 15, 2019 WOAG

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

Feb 15, 2019 WOAR

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 2, 2018 EXRA

SOU EXTENSION 2 GRANTED

Oct 31, 2018 EX2G

SOU EXTENSION 2 FILED

Oct 31, 2018 EXT2

SOU TEAS EXTENSION RECEIVED

Oct 31, 2018 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 27, 2018 EXRA

SOU EXTENSION 1 GRANTED

Apr 25, 2018 EX1G

SOU EXTENSION 1 FILED

Apr 25, 2018 EXT1

SOU TEAS EXTENSION RECEIVED

Apr 25, 2018 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 31, 2017 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 5, 2017 NPUB

PUBLISHED FOR OPPOSITION

Sep 5, 2017 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 16, 2017 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 31, 2017 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 28, 2017 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 28, 2017 CRFA

ASSIGNED TO LIE

Jul 25, 2017 ALIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 20, 2017 TROA

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

Jun 9, 2017 GEAN

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

Jun 9, 2017 GEAP

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

Jun 9, 2017 EPEN

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

Jun 9, 2017 CPEA

ASSIGNED TO EXAMINER

Jun 7, 2017 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 9, 2017 NWOS

NEW APPLICATION ENTERED

May 8, 2017 NWAP

Related Trademarks

More from this Owner

ALITAIR

ALITAIR.COM

ALITAIR

BENZONATATE POLACRILEX

HELPING THE WORLD BREATHE EASIER

More in Same Class

HIKERS' FRIEND

FREEZ!O

TIMOLOL, BRIMONIDINE, DORZOLAMIDE, AND LATANOPROST 0.5% / 0.2% / 2% / 0.005% OMNI BY OCULAR SCIENCE

MOXIFLOXACIN HCL 0.5% OMNI BY OCULAR SCIENCE

DEXAMETHASONE PO4 AND MOXIFLOXACIN HCL 0.1% / 0.5% OMNI BY OCULAR SCIENCE

DEXAMETHASONE PO4, MOXIFLOXACIN HCL, BROMFENAC SODIUM SESQUIHYDRATE 0.1% / 0.5% / 0.007% OMNI BY OCULAR SCIENCE